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To characterize the lipid profile in vaginal discharge of women with vulvovaginal candidiasis,
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Sample
Twenty-four women were included in this study: eight with vulvovaginal candidiasis, eight
with cytolytic vaginosis and eight with no vaginal infections or dysbiosis (control group).
Methods
The lipid profile in vaginal discharge of the different study groups was determined by liquid
chromatography-mass spectrometry and further analyzed with MetaboAnalyst 3.0 platform.
Main outcome measures
Vaginal lipids concentration and its correlation with vulvovaginal candidiasis and cytolytic
vaginosis.







Citation: Sanches JM, Giraldo PC, Amaral R,
Eberlin MN, Marques LA, Migliorini I, et al. (2018)
Vaginal lipidomics of women with vulvovaginal
candidiasis and cytolytic vaginosis: A non-targeted
LC-MS pilot study. PLoS ONE 13(8): e0202401.
https://doi.org/10.1371/journal.pone.0202401
Editor: Manuel Portero-Otin, Universitat de Lleida-
IRBLLEIDA, SPAIN
Received: November 15, 2017
Accepted: August 2, 2018
Published: August 22, 2018
Copyright: © 2018 Sanches et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This study was supported by the
Research Support Foundation of Sao Paulo
(FAPESP) (2016/18850-9 to Mr. José Marcos
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Results
PCA, PLS-DA and hierarchical clustering analyses indicated 38 potential lipid biomarkers
for the different groups, correlating with oxidative stress, inflammation, apoptosis and integ-
rity of the vaginal epithelial tissue. Among these, greater concentrations were found for Gly-
cochenodeoxycholic acid-7-sulfate, O-adipoylcarnitine, 1-eicosyl-2-heptadecanoyl-glycero-
3-phosphoserine, undecanoic acid, formyl dodecanoate and lipoic acid in the vulvovaginal
candidiasis group; N–(tetradecanoyl)-sphinganine, DL-PPMP, 1-oleoyl-cyclic phosphatidic,
palmitic acid and 5-aminopentanoic acid in the cytolytic vaginosis group; and 1-nonadeca-
noyl-glycero-3-phosphate, eicosadienoic acid, 1-stearoyl-cyclic-phosphatidic acid, 1-
(9Z,12Z-heptadecadienoyl)-glycero-3-phosphate, formyl 9Z-tetradecenoate and 7Z,10Z-
hexadecadienoic acid in the control group.
Conclusions
Lipids related to oxidative stress and apoptosis were found in higher concentrations in
women with vulvovaginal candidiasis and cytolytic vaginosis, while lipids related to epithelial
tissue integrity were more pronounced in the control group. Furthermore, in women with cyto-
lytic vaginosis, we observed higher concentrations of lipids related to bacterial overgrowth.
Introduction
The instability surrounding the vaginal ecosystem is a well-known fact in the gynecological
practice, and such variations may derive from a variety of physiological or external factors.
The vaginal microbiota is constituted by microorganisms that promote local environmental
balance and its maintenance is established by complex interactions between the regular micro-
biota, the microbial metabolic products, the regular hormonal status and the host’s immune
response [1].
A high number of women are affected by vulvovaginal diseases such as vulvovaginal candi-
diasis (VVC) and cytolytic vaginosis (CV). Both conditions present very similar symptomatol-
ogy and, for this reason, they are commonly mistaken in the clinical practice, leading to
misdiagnosis and inappropriate choice of treatment [2]. Nevertheless, subtle distinctions can
be made between them. VVC produces a white and thick vaginal discharge, with vulvovaginal
pruritus and eventually pain and vulvovaginal fissure. Its intense inflammatory process results
from epithelium aggression caused by a fungus, usually Candida albicans [3]. On the other
hand, CV contains no sort of infection; instead, it is a dysbiosis, consisting of an intense prolif-
eration of lactobacillus that leads to cell lysis, histamine discharge and, ultimately, vaginal epi-
thelial scaling. Rather than pruritus, CV patients often report vulvovaginal burning that is
accentuated in the premenstrual period, thus mimicking vulvovaginal candidiasis. Moreover,
CV is not accompanied by a cellular inflammatory process as observed in VVC [2,4,5].
The development of metabolome analysis through mass spectrometry allowed researchers
to reach a correct interpretation of the quantitative and qualitative metabolic profile of one
organism or biological system, considering the metabolites composition and dynamics with
respect to genetic, physiological and environmental factors [6,7]. Lipidomics has emerged as a
segment closely related to metabolomics and is dedicated to the global study of lipids, includ-
ing their biochemical characteristics and networks formed within biological systems [8–11].
Nowadays, lipidomics studies are inclined to consider lipids as part of a broad integrated
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system of pathophysiological processes, instead of individual molecular structures with iso-
lated functions [8].
The study of lipids composing the vaginal ecosystem is a new and promising perspective for
better understanding gynecological conditions and their pathophysiological mechanisms. In
this context, the objective of our study was to characterize the lipid profile in vaginal discharge
samples of women with VVC, CV or no infection or dysbiosis, in order to enable improvement
of diagnosis and treatment success.
Methods
Study population and clinical evaluation
A cross-sectional pilot study carried out at the Genital Infections Ambulatory of the Depart-
ment of Tocogynecology of the University of Campinas included 24 sexually active, in con-
traceptive use, non-pregnant women aged 18 to 42 years. Experimental groups were divided
and named as follows (n = 8): 1) VVC group: women with vulvovaginal candidiasis; 2) CV
group: women with cytolytic vaginosis; 3) NL group: women without any type of vaginal infec-
tion or dysbiosis. The study was approved by the Ethics and Research Committee at the Uni-
versity of Campinas, CAAE n˚ 60648016.8.0000.5404, and written informed consent was
obtained from all participants.
The participants were submitted to a specular examination for collection of vaginal samples
by Dacron sterile swabs in order to perform lipid analyses and bacterioscopy by Gram stain.
The characterization of the VVC group was based on the presence of yeast, pseudohyphae or
blastospores in the vaginal discharge by microscopic examination by Gram stain, further con-
firmed by growth in Sabouraud culture media (Becton-Dickinson, Sparks, MD, USA). The cri-
teria used for the diagnosis of CV included white and flocculated vaginal discharge
accompanied by itching and/or burning at clinical evaluation, and Gram stain examination
revealing presence of vaginal epithelial cell lysis, high number of Lactobacillus morphotypes,
absence of leukocytes or microbial pathogens, and negative Candida sp culture.
Equivocal cases of endocervicitis, with presence of blood, bacterial vaginosis, trichomonia-
sis and/or mixed infections were ruled out. Bacterial vaginosis was diagnosed by the Amsel cri-
teria [12] and Nugent score 7[13]. Infection by Trichomonas vaginalis was identified by the
visualization of inflammatory cells in the vaginal smear by bacterioscopy (Gram stain) and
predominance of coccoid and coccobacillary bacteria, as well as the visualization of the proto-
zoan in fresh microscopy.
Lipid analysis of the vaginal samples
Two samples of the vaginal content of each patient were collected using sterile swabs and
immediately stored in dry 10-mL tubes at -80˚C, until processing.
For extraction of lipids, the samples were randomized and each sample was resuspended in
1 mL of 1:2 CHCl3: MeOH solution (Sigma, Basel, Switzerland), followed by the addition of
0.33 mL of CHCl3 and 0.33 mL of deionized water. The extraction was made in 15-mL glass
tubes. The solution was then stirred for 5 minutes, followed by centrifugation at 13,000 rpm
for 5 minutes. The supernatant was discarded, and the bottom layer of the sample containing
the lipid fraction was transferred to 1.5-mL glass tubes. All samples were dried using SpeedVac
for 30 minutes at 30˚C and kept frozen at -80˚C until the date of analysis.
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Data acquisition
Lipid chromatographic separation was performed by ultra-high performance liquid chroma-
tography (UHPLC) Agilent 1290 Infinity system (Agilent, Santa Clara, California, USA) and
chromatographic elution was performed on Kinetex C18 column (4.6 mm x 50 mm x 2.6 μm)
(Phenomenex, Torrance, CA, USA). For the positive ion mode, the aqueous mobile phase A
solvent was 0.1% formic acid and phase B solvent was methanol; for the negative ion mode,
phase A solvent was 5 mM Ammonium Acetate and phase B solvent was methanol. Before
injection, the samples were randomized and inserted in the properly order. The mobile phase
flow rate was 0.3 mL min-1 and the injection volume was 2 μL. The mobile phase gradient
started at 5% of phase B changing linearly to 95% of phase B within 15 minutes and then
returning to the initial composition, at which the gradient was kept constant for 5 minutes
until the next run. This gradient profile was used for both positive and negative ion modes.
Mass spectrometry
To obtain the mass spectra of samples in positive and negative ion modes, a hybrid mass spec-
trometer with QTOF 6550 mass analyzer (Agilent, Santa Clara, California, USA) was used.
The instrumental parameters of the electrospray ionization source used in this study for both
positive and negative ion modes were: VCap of 3,000 V; 100 V shredder voltage, 65 V skimmer
voltage, 750 V OCT 1 RF Vpp, 290˚C Gas Temperature, 350˚C Sheath Gas Temperature, 12 L.
min-1 Sheath Gas Flow. The mass spectra were acquired in centroid mode and the mass range
used for acquisition was 50–1700 Da.
Data processing
The raw data obtained was converted to the mzData format using the MassHunter Qualitative
software (Agilent, Santa Clara, California, USA), eliminating isotopic interference. After con-
version, the files were imported into the XCMS online software[14] for peak detection, align-
ment, retention time correction and other relevant pre-processing steps.
The data obtained from the online XCMS software was converted into an Excel table. Data
normalization, scaling, hierarchical clustering into heatmaps and multivariate statistical analy-
sis were performed in the MetaboAnalyst 3.0 platform [15]. Metabolites with a value of
p< 0.05 (ANOVA) were considered representative for further investigation. Exploratory mul-
tivariate data analysis was performed using the Principal Component Analysis (PCA) unsuper-
vised method and the Partial Least Squares Discriminant Analysis (PLS-DA), allowing
selection of molecules with a VIP index higher than 1.0 as potential biomarkers. Putative lipid
identification of the selected biomarkers was performed by measurement of their exact mass,
retention time and elution profile, and further matching of such compounds in METLIN [14],
Human Metabolome Database (HMDB) [16] and Lipid Maps databases [17].
Results
PCA and PLS-DA analyses
Comparison between VVC, CV and nl groups with regard to the main lipid components was
performed by PCA and PLS-DA analyses (Fig 1). Fig 1A and 1C refer to the PCA in positive
and negative ion modes, respectively. Both graphs show that the CV ellipses are separated
from the other groups, indicating that women with CV manifest a very distinct lipid composi-
tion. Larger overlaid area of VVC and nl ellipses in the positive ion mode characterizes a cer-
tain similarity between these groups. In the PLS-DA Parameter Score charts (Fig 1B and 1D),
separation of the CV group from the VVC and nl groups was more pronounced when
Vulvovaginal candidiasis and cytolytic vaginosis lipidomics
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Fig 1. Score plots analysis of the lipid fraction of vaginal samples from CV (red), nl (green) and VVC (blue) groups. A: PCA analysis in the positive ion mode. C: PCA
analysis in the negative ion mode. B: PLS-DA analysis in the positive ion mode. D: PLS-DA analysis in the negative ion mode.
https://doi.org/10.1371/journal.pone.0202401.g001
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compared to the PCA, and this difference was probably due to the unsupervised nature of the
latter method.
The PLS-DA model also provides the VIP score, which is a measure of a variable’s impor-
tance in the analysis. Figs 2 and 3 show the lipids with the highest VIP scores and their respec-
tive concentrations in the vaginal samples. As these molecules were the most contributory in
the model, they were selected as potential biomarkers for the different experimental groups.
Hierarchical clustering of lipids concentration by sample
Fig 4 shows the hierarchical clustering of lipids in the form of heatmaps and dendrograms,
demonstrating the proportion of significantly altered lipid components, identified as potential
lipid biomarkers of the studied groups. Results from this analysis confirmed some of the lipid
proportions already evidenced by the former methods, as described below.
In VVC women, there was a higher concentration of Glycochenodeoxycholic acid 7-sulfate,
1-(1Z-eicosenyl)-2-octadecanoyl-glycero-3-phosphoethanolamine, O-adipoylcarnitine,
1-eicosyl-2-heptadecanoyl-glycero-3-phosphoserine in comparison with the control and CV
groups. On the other hand, CV women showed higher concentrations of N–(tetradecanoyl)
sphinganine, DL-PPMP and 1-(11Z-docosenoyl)-glycero-3-phosphate in relation to the other
groups. The main potential lipid biomarkers of the control group (nl) were identified as 1-non-
adecanoyl-glycero-3-phosphate and 1-(9Z, 12Z-octadecadienoyl)-glycero-3-phospho-(1’-sn-
glycerol). Several lipids presented similar concentrations especially between the VVC and nl
groups, thus corroborating the overlapping ellipses found in the PCA and PLS-DA analyses.
Moreover, the negative ionization mode showed the highest contrasts of lipid concentrations
for VVC and CV groups. In this sense, the most expressive lipid biomarkers were undecanoic
acid, formyl dodecanoate and lipoic acid for the VVC group, and 1-oleoyl-cyclic phosphatidic,
palmitic acid and 5-aminopentanoic acid for the CV group. In parallel, eicosadienoic acid,
1-stearoyl-cyclic-phosphatidic acid, 1-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphate, formyl
Fig 2. PLS-DA analysis in the positive ion mode revealing the 15 lipid molecules with the highest VIP scores and their respective concentrations in the vaginal
samples from CV, nl and VVC groups.
https://doi.org/10.1371/journal.pone.0202401.g002
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9Z-tetradecenoate and 7Z,10Z-hexadecadienoic acid were the main potential biomarkers for
the control group.
Considering all methods of analysis, in both negative and positive ion modes, we found 38
potential biomarkers that allow distinction between the VVC, CV and control groups.
Discussion
Our lipidomics study showed significant differences between women with VVC and CV
regarding the lipid composition of vaginal discharge samples. Herein, we showed that lipids
play an important role in the maintenance of the vaginal microenvironment homeostasis and
that lipids profile can be markedly altered during pathophysiological processes. To our knowl-
edge, this phenomenon had not yet been described in the current literature.
Moreover, several VVC potential lipid biomarkers were possibly related to inflammation.
Among them, we found high concentrations of O-Adipoylcarnitine, belonging to the family of
Acyl carnitines, which are intermediate oxidative metabolites synthesized by the mitochondria
and peroxisomes, with the objective of transporting long-chain fatty acids for the process of β-
oxidation [18,19]. Long-chain fatty acids can persistently modify biological processes, such as
cellular stress [20], ionic variations [21] and inflammation [22]. Another lipid biomarker found
in the VVC group, the 15-methyl-15S-prostaglandin D2 may act as a mediator of inflammation
resulting from the vaginal mucosa response to the virulence factor of Candida sp.
Studies have shown that the oxidation of fatty acids typically occurs in tissues submitted to
oxidative stress, including sites of inflammation [23,24]. Indeed, in the present investigation, a
number of the selected biomarkers were found to be potentially related to oxidative stress.
Fig 3. PLS-DA analysis in the negative ion mode revealing the 15 lipid molecules with the highest VIP scores and their respective concentrations in the vaginal
samples from CV, nl and VVC groups.
https://doi.org/10.1371/journal.pone.0202401.g003
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13S-hydroperoxide-9Z,11E,14Z-octadecatrienoic acid, pointed in our study as the lipid bio-
marker with the highest VIP score in women with VVC (negative ion mode data), is typically
produced by lipid peroxidation and can accumulate in mitochondrial membranes, enabling
mitochondrial degradation and cellular damage [25–27]. Consistently, the glycochenodeoxy-
cholic-acid-7-sulfate is the smallest of fatty acids metabolites whose excretion is increased
when there are errors in mitochondrial metabolism, being suitable to diagnose mitochondrial
Fig 4. Hierarchical clustering of lipids with regard to their relative concentration in each vaginal sample from VVC (red dendrogram columns), CV (blue
dendrogram columns) and nl (green dendrogram columns) groups (n = 8). High concentrations of lipids are shown in shades of red and low concentrations are shown
in shades of blue. A: analysis performed in the positive ion mode. B: analysis performed in the negative ion mode.
https://doi.org/10.1371/journal.pone.0202401.g004
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beta-oxidation disorders [28, 29]. In our study, this compound was found in considerable pro-
portions in the vaginal discharge of women with VVC and could be associated with mitochon-
drial deregulations in response to the oxidative stress caused by Candida sp.
A possible biological mechanism against oxidative stress and inflammatory process is the
production of antioxidant metabolites or even by oral treatment, such as the lipoic acid [30,
31]. In its reduced form, dihydrolipoic acid, such compound has been described as a metabo-
lite of fundamental importance to counterbalance reactive oxygen species [32–34]. In our
study, lipoic acid was found as a potential biomarker of VVC, also possibly related to the vagi-
nal mucosa response against Candida sp. oxidative stress.
Likewise, undecanoic acid was found at higher concentrations in the VVC group and seems
to present antifungal and oxidative stress defense properties. This compound is an endogenous
fatty acid commonly found in body fluids, and is involved in cell signaling, integrity and stabil-
ity of biological membranes [35]. Studies have shown that the administration of undecanoic
acid together with palmitic acid has resulted in antifungal activity [36] and inhibition of the
morphogenesis of Candida albicans, preventing the development of blastospores into hyphae
[37]. Thus, the presence of this lipid in women with VVC indicates a tissue response to Can-
dida sp. infection.
Interestingly, palmitic acid was found at high concentrations only in the CV group. This
compound is the most prominent fatty acid used by the human body [38]. Studies with rats
have shown that palmitic acid increases endoplasmic reticulum stress, apoptosis in endothelial
cells [39], increases endothelial nitric oxide synthase phosphorylation [40] and increases the
formation of ROS and NADPH oxidase in skeletal muscles [41]. Therefore, CV lipid profile
was also influenced by oxidative stress, probably caused by the exacerbated increase of lactoba-
cilli producing lactic acid and other organic acids.
N-(tetradecanoyl) sphinganine and DL-threo-1-phenyl-2-palmitoylamino-3-morpholino-
1-propanol (DL-PPMP) were also indicated as potential biomarkers for CV in our study. Both
are precursors of apoptosis [42–44], possibly due to the homeostatic disturbance related to the
low pH (3.5 to 4.5) that is characteristic of this vaginosis [5]. Additionally, the increase in the
levels of palmitoleic acid and 1-oleoyl-cyclic phosphatidic acid in the CV group was consistent
with the role of these acids on injured epithelial tissues, already described this relation in
hepatic cells [45]. Our results showed the presence of these potential lipids biomarkers in CV
group which can be inferred the possible relation of injured caused on the vaginal epithelium
visualized on the Gram stain.
In the present report, lipid biomarkers such as the phosphatidylserines fatty acids phospha-
tidylinositol and phosphatidylglycerophosphate, involved in cell signaling such as apoptosis,
signal transduction of the plasmatic membrane and cardiolipin precursors [35, 46], showed
higher concentrations in the VVC group.
The 5-aminopentanoic acid can be produced endogenously or by the bacterial catabolism
of lysine, and it is known to act on the growth of anaerobic bacteria [47, 48]. In contrast, the
presence of this biomarker in high concentrations in the CV group, where there is predomi-
nance of lactobacilli, raises new questions about the function of this compound in situations
where there is an overpopulation of aerobic bacteria.
Among the main lipids identified in the control group (nl), the eicosadienoic acid presented
relevant concentrations in comparison to the other study groups. This compound is an omega-
6 fatty acid whose synthesis is linked to several receptors that can be found in various tissues of
the human body [35, 49, 50]. The eicosadienoic acid is an antagonist of the leukotriene B4 recep-
tor [51], and both leukotrienes and prostanoids act in the body in autocrine and paracrine regu-
lation, influencing many physiological and pathophysiological mechanisms within the cell [52].
This organic acid can be related to anti-inflammatory mechanisms exerting a protective control
Vulvovaginal candidiasis and cytolytic vaginosis lipidomics
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of inflammatory mediators [53]. In addition, the presence of glycerophospholipids as potential
biomarkers in the control group supports the function normality of the vaginal epithelial tissue,
as these lipids are commonly found in the human organism [35, 54].
Furthermore, tocopherols are lipids associated with the cell membranes, acting against the
most reactive forms of free radicals, besides preventing lipid peroxidation and bacterial trans-
location, hence reducing tissue injuries [55–58]. Our study demonstrated a higher concentra-
tion of gamma-tocopherol in the control group, which is a derivative of vitamin E. Notably,
this lipid is important for the vaginal epithelial tissue homeostasis as it acts as a protector
against disorders in the local microenvironment, such as the oxidative stress caused by infec-
tions and dysbioses. Another antioxidant lipid biomarker found in the control group was
myristic acid, which has been described as improving the bioavailability of polar antioxidant
molecules in the organism [59], besides exerting antimicrobial activities [60].
Conclusion
From the lipidomic point of view, we are facing three distinguishable vaginal profiles. In
women with VVC, we found a higher concentration of lipids related to inflammation and oxi-
dative stress, while in CV women, we observed a higher concentration of lipids related to cellu-
lar apoptosis, oxidative stress and bacterial overgrowth. In control women, vaginal lipidome
was characterized by the presence of lipids involved in the maintenance of epithelial integrity
epithelium and anti-inflammatory and antioxidant functions.
For clinical practice, this work provides some answers and new insights about the lipid
metabolism involved in the pathophysiological processes of VVC and CV. Studies with larger
population and targeting specifics lipids biomarkers can provide subsidies for better definition
of conduct and treatment for women affected by these so frequent gynecological disorders.
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